Dan Thomas Stinchcomb
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2006First federal award
$7.9MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $7.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 30, 2011 | NIH | NIH N01 Development of Technologies to Facilitate the Use of and Response to Vaccines | $1.4M | INVIRAGEN, INC. |
| Aug 31, 2010 | NIH | NIH N01 Development of Technologies to Facilitate the Use of and Response to Vaccines | $1.8M | INVIRAGEN, INC. |
| Sep 1, 2009 | NIH | SBIR/STTR Phase I Second Generation Dengue Vaccine | $300K | INVIRAGEN, INC. |
| Sep 1, 2009 | NIH | SBIR/STTR Phase I Second Generation Dengue Vaccine | $300K | INVIRAGEN, INC. |
| May 4, 2007 | NIH | SBIR/STTR Phase I MVA-based vaccines against highly pathogenic avian influenza | $300K | INVIRAGEN, INC. |
| May 4, 2007 | NIH | SBIR/STTR Phase I MVA-based vaccines against highly pathogenic avian influenza | $289K | INVIRAGEN, INC. |
| Sep 26, 2006 | NIH | NIH U01 Preclinical development of a chimeric tetravalent dengue vaccine | $419K | INVIRAGEN, INC. |
| Sep 26, 2006 | NIH | NIH U01 Preclinical development of a chimeric tetravalent dengue vaccine | $488K | INVIRAGEN, INC. |
| Sep 26, 2006 | NIH | NIH U01 Preclinical development of a chimeric tetravalent dengue vaccine | $772K | INVIRAGEN, INC. |
| Sep 26, 2006 | NIH | NIH U01 Preclinical development of a chimeric tetravalent dengue vaccine | $1.2M | INVIRAGEN, INC. |
| Mar 15, 2006 | NIH | SBIR/STTR Phase I Mucosal modified vaccinina Ankara-based plaque vaccines | $358K | INVIRAGEN, INC. |
| Mar 15, 2006 | NIH | SBIR/STTR Phase I Mucosal modified vaccinina Ankara-based plaque vaccines | $310K | INVIRAGEN, INC. |
Peer ranks
Federal funding#3
Awards as PI#3
Patents#14
Companies
- INVIRAGEN, INC.Linked by awards
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.